FRAZIER MANAGEMENT LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$54,984,000
+81.6%
3,123,1070.0%4.40%
+57.6%
Q2 2021$30,275,000
-9.4%
3,123,1070.0%2.79%
+4.2%
Q1 2021$33,419,000
-25.5%
3,123,107
+2.3%
2.68%
-22.5%
Q4 2020$44,879,000
+13.5%
3,053,107
+9.5%
3.46%
-2.7%
Q3 2020$39,555,000
+77.5%
2,788,443
+1.2%
3.55%
+81.5%
Q2 2020$22,288,000
+133.3%
2,755,000
+12.7%
1.96%
+80.7%
Q1 2020$9,552,0002,443,8091.08%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders